Rolling review--the pathogenesis, diagnosis and management of viral hepatitis.
Five major hepatotrophic viruses have been identified. The pathogenesis, diagnosis and treatment of chronic viral hepatitis continues to be intensely researched. Experimental evidence suggests that HLA restricted virus-specific T cells play a role in hepatocellular injury in type A hepatitis. The absence of chronic infection indicates the effectiveness of the host immune response to hepatitis A virus (HAV). It is postulated that HAV may rarely trigger an autoimmune chronic hepatitis. Active prophylaxis of hepatitis A is possible. The elimination of hepatitis B is dependent on the recognition of viral determinants in association with HLA proteins on infected hepatocytes by cytotoxic T cells. The specific epitopes recognized by B and T cells are being mapped. Polymerase chain reaction (PCR) amplification and sequencing of genomic DNA in patients with chronic hepatitis B has indicated that nucleotide substitutions in the genome are not uncommon. Their pathogenicity is being explored. Antiviral therapy for hepatitis B remains difficult. Interferon is effective in a proportion of patients. Thymosin may prove to be more effective immunomodulatory therapy. New nucleoside analogues suppress HBV replication, but the safety of these drugs has been questioned after the appearance of severe liver toxicity with fialuridine. The data that hepatitis D virus is pathogenic has recently been challenged with the observation that HDV re-occurs in transplanted liver after engrafting, but without signs of HBV recurrence or evidence of liver damage. Treatment of hepatitis D virus remains difficult. Several isolates of hepatitis C virus have been cloned, and the sequence divergence of these isolates indicates that there are several major genotypes and component subtypes of this polymorphic virus.(ABSTRACT TRUNCATED AT 250 WORDS)
Royal Free Hospital and School of Medicine, London, UK.
G M
GM
Dusheiko
D000818:Animals; D000956:Antigens, Viral / Q000302:isolation & purification; D000998:Antiviral Agents / Q000627:therapeutic use*; D002908:Chronic Disease; D016679:Genome, Viral; D006518:Hepatitis Viruses / Q000235:genetics / Q000276:immunology*; D006525:Hepatitis, Viral, Human / Q000175:diagnosis / Q000209:etiology / Q000276:immunology / Q000628:therapy; D006801:Humans; D016031:Liver Transplantation; D012367:RNA, Viral / Q000302:isolation & purification; D014761:Viral Hepatitis Vaccines / Q000008:administration & dosage
D000956:Antigens, Viral; D000998:Antiviral Agents; D012367:RNA, Viral; D014761:Viral Hepatitis Vaccines